Mikkel Staberg

Copenhagen University Hospital — Denmark

Medicine · Health Sciences

5h-index274citations11works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(6), Histone Deacetylase Inhibitors Research(4), Epigenetics and DNA Methylation(3), Cancer, Hypoxia, and Metabolism(3), Angiogenesis and VEGF in Cancer(2)

Publications11 total

VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance
Neuro-Oncology·2018· 86 citedOpen Access
Targeting glioma stem‐like cell survival and chemoresistance through inhibition of lysine‐specific histone demethylase <scp>KDM</scp>2B
Molecular Oncology·2018· 73 citedOpen Access
DRES-01. ROLE OF HISTONE LYSINE DEMETHYLASE KDM2B IN GLIOBLASTOMA TUMOR CELL MAINTENANCE AND CHEMORESISTANCE
Neuro-Oncology·2017Open Access
Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine
Cellular Oncology·2016· 61 cited
P01.12 VEGF-C contributes to autocrine VEGF Receptor 2 signaling and cellular maintenance in Glioblastoma
Neuro-Oncology·2016Open Access
Combined EGFR- and notch inhibition display additive inhibitory effect on glioblastoma cell viability and glioblastoma-induced endothelial cell sprouting in vitro
Cancer Cell International·2016· 12 citedOpen Access
ANGI-15COMBINED TARGETING OF NOTCH AND EGFR DISPLAY ADDITIVE INHIBITORY EFFECTS ON ANGIOGENESIS AND SURVIVAL IN GLIOBLASTOMA
Neuro-Oncology·2015Open Access
Abstract 1369: Inhibition of Notch- and EGFR signaling reduces cell viability and angiogenesis in glioblastoma multiforme
Cancer Research·2015· 1 cited
The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients
Cancer Management and Research·2014· 36 citedOpen Access
P01.20 * EPIGENETIC TREATMENT AND INDUCTION OF DIFFERENTIATION IN GLIOBLASTOMA MULTIFORME NEUROSPHERE CELLS LEADS TO DOWNREGULATION OF EGFR, EGFRVIII AND NESTIN TOGETHER WITH REDUCED COLONY FORMATION IN VITRO
Neuro-Oncology·2014· 1 citedOpen Access
Identification of a novel antagonist of the ErbB1 receptor capable of inhibiting migration of human glioblastoma cells
Cellular Oncology·2013· 4 cited

Frequent Co-authors

Signe Regner Michaelsen(9), Hans Skovgaard Poulsen(9), Mette Villingshøj(8), Petra Hamerlik(7), Mette Kjølhede Nedergaard(4), Henriette Pedersen(3), Rikke Rasmussen(3), Louise Stobbe Olsen(3), Kamilla E. Jensen(2), Helle Broholm(2), Thomas Urup(2), Jane Skjøth‐Rasmussen(2), Jannick Brennum(2), Ulrik Lassen(2), Marie‐Thérése Stockhausen(2), Wiktor W. Majewski(1), Christopher Meulengracht(1), Slávka Lukacova(1), Andreas Kjær(1), Kristoffer Vitting‐Seerup(1)